Ivosidenib (TIBSOVO®) Combined With Azacitidine According to Current SmPC

NCT06181734 · clinicaltrials.gov ↗

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia (AML)

Interventions

DRUG: Ivosidenib

Sponsor

iOMEDICO AG